2010
DOI: 10.1097/01.pra.0000386907.99536.75
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Long-Term Psychoanalytic Treatment on Healthcare Utilization and Work Impairment and Their Associated Costs

Abstract: Long-term psychoanalytic treatment is perceived as an expensive ambulatory treatment for mental illnesses. However, there are indications that psychoanalytic treatment can result in cost savings in the long term. In this study, we investigated the effects of long-term psychoanalytic treatment on healthcare utilization and work impairment and calculated the associated societal costs. We assessed healthcare utilization and work impairment of patients before, during, and after long-term psychoanalytic treatment (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
4
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 22 publications
2
4
0
Order By: Relevance
“…Furthermore, some reductions continued to increase in the years after therapy, indicating a possible long‐term dynamic effect of therapy. The findings are consistent with Berghout et al's (2010) results regarding the increase in saving during the second year after long‐term psychoanalytic treatment.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Furthermore, some reductions continued to increase in the years after therapy, indicating a possible long‐term dynamic effect of therapy. The findings are consistent with Berghout et al's (2010) results regarding the increase in saving during the second year after long‐term psychoanalytic treatment.…”
Section: Discussionsupporting
confidence: 92%
“…Kraft et al (2006), on the basis of 176 participants, found a rise in calculated semiannual cost prior to psychotherapy and a decrease in cost thereafter. Berghout, Zevalkink, and Hakkaart‐Van Roijen (2010), on a sample size of 231, assessed self‐report of sick leave days and health expenditure before psychoanalysis and at two points after it. They found a sustained reduction in sick leave days and health expenditure after psychoanalysis.…”
Section: Introductionmentioning
confidence: 99%
“…A limitation regarding the economic feasibility of long-term psychoanalytic treatment and hence justification for its Maintenance as a community mental health promotion service, is that an evaluation of its cost-benefit profile was not included in the study. Economic benefit has been demonstrated in other research on psychoanalytic psychotherapy (e.g., Berghout et al, 2010;Beutel et al, 2004;De Maat et al, 2007;Leuzinger-Bohleber et al, 2003) and remains a priority for further research. Nevertheless, heartened by the success of the implementation of its demonstration project, the VAPP aims to continue the program, while the VAPP and other psychotherapy groups in Victoria have continued to advocate for inclusion of psychoanalytic psychotherapy in the State public mental health system.…”
Section: Discussionmentioning
confidence: 92%
“…1 Further, systematic outcome studies of long-term psychoanalytic psychotherapy (Kernberg, 2006) have demonstrated economic benefits that justify its wider availability in communities. Substantial reductions of general health care and sick leave use, work absenteeism (Leuzinger-Bohleber et al, 2003), with break-even cost-benefit approximately 3 years post termination (De Maat et al, 2007), as well as increased workplace participation (Berghout et al, 2010;Beutel et al, 2004) have been found. STOPPP research has demonstrated symptom reduction rather than actual health care use, especially in Sweden (Lazar et al, 2006), and examined factors predicting improvement post-treatment (Falkenstrom et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…The ethical dilemma is akin to a situation where there is a limited supply of penicillin in the midst of an epidemic of pneumonia: does one give half the recommended dose to everybody or a full recommended dose to half? Fortunately, limited services and medication are sufficient for some, but many others are recurrently and chronically ill and need more intensive and/or extended psychotherapy, to include those with chronic depression (Blatt, Quinlan, Pilkonis, & Shea, 1995;Buchheim et al, 2012;Fava, Ruini, & Belaise, 2007;Huber, Zimmerman, Henrich, & Klug, 2012) and those with borderline personality disorder (Bateman & Fonagy, 2008;Stevenson & Meares, 1999) as well as other patient groups (Berghout, Zevalkink, & Hakkaart-vanRojen, 2010a, 2010bBeutel, Rasting, Stuhr, Rüger, & Leuzinger-Bohleber, 2004;De Maat, de Jonghe, Schoevers, & Dekker, 2009;De Maat, Philipszoon, Schoevers, Dekker, & De Jonghe, 2007;Howard, Kopta, Krause, & Olinski, 1986;Leichsenring & Rabung, 2008, 2011Sandell et al, 2000).…”
Section: How Will Ecps Make Their Choices?mentioning
confidence: 99%